COMP <GO>
KLRS vs INKT // ENTERPRISE SCALE & MARKET CAP
Kalaris Therapeutics Inc. (NASDAQ) VS. MiNK Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: KLRS 1
— INKT 2
▲ ENTERPRISE SCALE & MARKET CAP LEADER: INKT
LAST: $2.13 (+5.97%) • MKT CAP: $50.7M
market-cap
$50.7M
LAST: $10.88 (+0.69%) • MKT CAP: $55.5M
market-cap
$55.5M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KLRS VS. INKT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | KLRS | INKT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -10.68% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 2/9 | +1.00 | KLRS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.4 | 46.1 | -4.73 | INKT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $50.7M | $55.5M | -$4.8M | INKT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | KLRS REV | INKT REV | KLRS GROSS % | INKT GROSS % | KLRS FCF | INKT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $0 | — | — | -$38.6M | -$5.9M |
| FY 2024 | $0 | $0 | — | — | -$20.7M | -$9.6M |
| FY 2023 | $0 | $0 | — | — | -$124.5M | -$15.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KLRS // BETA —
INKT // BETA —